Infectious Disease Alert (Vol. 35, No. 7) - April 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: April 2016

Valid through: April 2019

Target Audience

This activity is intended for the infectious disease specialist.

Subjects

  • Trimethoprim-sulfamethoxazole versus Placebo for Skin Abscesses After Incision and Drainage
  • Pediatric Coccidioidomycosis in California, 2000-2012
  • Antibiotic Use in Treatment of Children with Uncomplicated Severe Acute Malnutrition
  • Saccharomyces Cerevisiae var boulardii (S. boulardii) and Antibiotic-associated Diarrhea
  • Early Chest CT Can Improve Treatment for Community-acquired Pneumonia
  • Infectious Disease Alert Updates

Objectives

  • Discuss the diagnosis of infectious diseases
  • Explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • Discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Credit Available

Physicians

  • Maximum of 3.0 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine, Stanford University

Philip R. Fischer, MD, DTM&H

Professor of Pediatrics

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN

Simrit K. Warring, Medical Student, Mayo Medical School, Rochester, MN

Richard R. Watkins, MD, MS, FACP

Division of Infectious Diseases, Akron General Medical Center, Akron, OH,

Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH

Dean Winslow, MD

Professor of Medicine, Division of General Medical Disciplines, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine

Samuel Nadler, MD, PhD

Critical Care, Pulmonary Medicine, The Polyclinic Madison Center, Seattle; Clinical Instructor, University of Washington, Seattle

Carol Kemper, MD, FACP,

Clinical Associate Professor of Medicine, Stanford University, Division of Infectious Diseases, Santa Clara Valley Medical Center

Editors

Physician Editor:

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine,
Stanford University.

AHC Media Executive Editor: Shelly Morrow Mark

Financial Disclosure

Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, reports no financial relationships relevant to this field of study; peer reviewer Patrick Joseph, MD, is laboratory director for Genomic Health Laboratory, Siemens Clinical Laboratory, and CareDx Laboratory. Updates author, Carol A. Kemper, MD, FACP, continuing education and editorial director Lee Landenberger, executive editor Shelly Morrow Mark, and associate managing editor Jonathan Springston report no financial relationships to this field of study.

Dr. Richard Watkins has received research support from Actavis. Dr. Philip Fischer, Simrit Warring, Dr. Dean Winslow, and Dr. Samuel Nadler report no financial relationships relevant to this field of study.

 

Copyright 2016, AHC Media. All rights reserved.